Inj. Bimzelx 160mg (Bimekizumab Injection) 160mg

Bimekizumab injection 160mg is a prescription biologic used to treat moderate to severe plaque psoriasis and psoriatic arthritis. This 2-dose pack is administered subcutaneously and requires refrigeration between 2–8°C. Always follow handling instructions to maintain potency and safety.

Strength

160mg

Pack Size

Storage

2-8°

Manufacturer / TM Owner

UCB PHARMA, INC.

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

Bimekizumab 160mg injection is prescribed for adults with moderate to severe plaque psoriasis who are candidates for systemic therapy or phototherapy. It is also used to treat active psoriatic arthritis in adults when other treatments have not been effective. This biologic works by targeting specific proteins involved in inflammation.

Side Effects

After administration, some users may notice a reduction in skin plaques or joint discomfort over time. Individual responses vary, and visible improvements may take several weeks to appear. Temporary redness or swelling at the injection site is commonly reported.

Precautions & Warnings

Keep the injection refrigerated at 2–8°C and protect it from light. Do not freeze or shake vigorously. Allow the prefilled syringe to reach room temperature for 30 minutes before use. Discard any unused product after the stated expiration date on the label.

Avoid Interactions

Bimekizumab may interact with live vaccines, so avoid receiving them during treatment. Caution is advised when combining with other immunosuppressants or biologics. Always inform your healthcare provider about all medications and supplements currently in use.

Frequently Asked Questions

Store the injection in the refrigerator between 2–8°C. Do not freeze or expose to direct light.

Contact your healthcare provider for guidance if a dose is missed. Do not take a double dose to make up for a missed one.

Yes, but use a validated insulated bag with cooling packs to maintain the 2–8°C temperature range during transport.

The safety of Bimekizumab during pregnancy has not been established. Consult your healthcare provider for personalized advice.

Common effects include injection site reactions like redness or swelling. Some users may experience upper respiratory infections or headaches.

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical supplier

Last updated: 29 Jul 2026

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.